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Biological and Dosimetric Characterisation of Spatially 
Fractionated Proton Minibeams 
 
Abstract:  
The biological effectiveness of proton beams varies with depth, spot size and lateral distance from the beam 
central axis. The aim of this work is to incorporate proton relative biological effectiveness (RBE) and equivalent 
uniform dose (EUD) considerations into comparisons of broad beam and highly modulated proton minibeams. A 
Monte Carlo model of a small animal proton beamline is presented. Dose and variable RBE is calculated on a 
per-voxel basis for a range of energies (30-109 MeV). For an open beam, the RBE values at the beam entrance 
ranged from 1.02-1.04, at the Bragg peak (BP) from 1.3 to 1.6, and at the distal end of the BP from 1.4 to 2.0. 
For a 50 MeV proton beam, a minibeam collimator designed to produce uniform dose at the depth of the BP 
peak, had minimal impact on the open beam RBE values at depth. RBE changes were observed near the surface 
when the collimator was placed flush with the irradiated object, due to a higher neutron contribution derived 
from proton interactions with the collimator. For proton minibeams, the relative mean RBE weighted entrance 
dose (RWD) was ~25% lower than the physical mean dose. A strong dependency of the EUD with fraction size 
was observed. For 20 Gy fractions, the EUD varied widely depending on the radiosensitivity of the cells. For 
radiosensitive cells, the difference was up to ~50% in mean dose and ~40% in mean RWD and the EUD trended 
towards the valley dose rather than the mean dose. For comparative studies of uniform dose with spatially 
fractionated proton minibeams, EUD derived from a per-voxel RWD distribution is recommended for biological 
assessments of reproductive cell survival and related endpoints. 
 
Keywords: proton therapy, minibeam, variable relative biological effectiveness (RBE), linear energy transfer 
(LET), equivalent uniform dose (EUD), spatial modulation  
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1. Introduction 
Synchrotron-generated spatially fractionated microbeams have been reported to result in extraordinary normal 
tissue sparing (Dilmanian et al., 2002; Dilmanian et al., 2001; Dilmanian et al., 2003; Dilmanian et al., 2007; 
Bouchet et al., 2013; Bouchet et al., 2010; Serduc et al., 2008). The idea of utilizing microbeams is based on the 
pioneering work by Zeman and Curtis (Zeman et al., 1961; Zeman et al., 1959) at Brookhaven National 
Laboratory who, while conducting cosmic-ray research, discovered an inverse relationship between 
radiosensitivity and tissue volume exposed in mouse brain irradiated with a deuteron beam.  In the same lab 
three decades later, Slatkin et al. (Slatkin et al., 1992) proposed microbeam radiotherapy (MRT), as a way to 
spare normal tissue in thin plane-parallel synchrotron beams. The dimensions of the multi-planar arrays of X-ray 
beams are typically in the range of 20-100 µm full width at half maximum (FWHM) with a centre-to-centre 
(CTC) spacing of about 100-400 µm and dose rates up to the order of 104 Gy/s. More recently it has been 
reported by Dilmanian et al. (Dilmanian et al., 2006) that wider beams up to 680 µm width retain a normal 
tissue sparing effect, which has prompted research into alternative approaches to synchrotron-generated beams.  
Investigators at the Institute of Cancer Research in Sutton, UK (Bartzsch et al., 2016) proposed an MRT 
approach based on a conventional X-ray tube with microbeam dimensions of 50 µm beam width and 400 µm 
CTC spacing. Wider, but still submillimetre beams, are termed minibeams. Examples of X-ray based minibeam 
systems include the carbon nanotube based 160 kVp system at the University of North Carolina (Zhang et al., 
2014b) with a beam width of 280 µm. Proton based minibeam systems include the 100 MeV beam by the group 
in Orsay, France (Prezado and Fois, 2013; Peucelle et al., 2015; Guardiola et al., 2017), who demonstrated the 
first experimental implementation in 2014; the 20 MeV ion microprobe SNAKE by investigators in Munich 
(Girst et al., 2015a; Girst et al., 2016; Girst et al., 2015b; Zlobinskaya et al., 2013) who used a grid of 
submillimetre pencil beams, termed microchannels; and the work conducted in collaboration between 
Brookhaven National Laboratory and MD Anderson Cancer Center (Dilmanian et al., 2015b; Dilmanian et al., 
2015a), who investigated a 109 MeV beam with 300 µm width and 1 mm CTC spacing. We have recently 
presented a feasibility study for a 50.5 MeV proton minibeam (Lee et al., 2016a; Lee et al., 2016b) based on our 
image-guided precision proton radiation platform (PPRP) for preclinical in vivo research at the University of 
Washington (Ford et al., 2017). The multi-slit collimator was designed to produce a uniform dose at the depth of 
the Bragg Peak (BP), while retaining high modulation on the entrance side. The collimator dimensions are 
comparable to the above systems with 1 mm CTC spacing and 300 µm slit width.  
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To explore the expected biological response to this type of irradiation, and before biological experiments are 
conducted, exact knowledge of both the physical and biologically effective dose is crucial. It is often implicitly 
assumed that the RBE of low energy X-rays, as is used for synchrotron-generated microbeams, is close to unity 
even though a number of published studies (Nikjoo and Lindborg, 2010; Botchway et al., 1997; Fayard et al., 
2002; Hoshi et al., 1988; de Lara et al., 2001; Cornforth et al., 1989; Spadinger and Palcic, 1992) indicate lower 
energy (< 100-200 kV) X-rays are more biologically damaging per unit absorbed dose than 60Co -rays or MV 
X-rays. As an example, the RBE for DNA double strand break induction (RBEDSB) for a 60 kV X-ray beam (no 
filtration except 0.8 mm Beryllium exit window) is ~1.3 (Stewart et al., 2015). It is important to note also that 
there is a strong correlation between RBEDSB and the RBE for cell survival as demonstrated recently by 
Streitmatter et al. (Streitmatter et al., 2017). Those investigators demonstrated that the two RBE values were 
within a few percent of each other for electrons and photons with energies in the range from about 250 eV to 1 
MeV. Synchrotron-generated X-ray microbeams experiments have been reported to use median energies as low 
as 50-70 keV (Laissue et al., 1998; Dilmanian et al., 2002).  
 
For clinical proton beams, Monte Carlo simulations suggest that RBEDSB may be as large as 1.2 to 1.3 near the 
apogee of the BP (Stewart et al., 2015). A significant difference from the purported constant (spatially invariant) 
RBE value of 1.1 in common clinical use (Chaudhary et al., 2014). Distal to the BP, Monte Carlo simulations 
(Stewart et al., 2015) suggest that RBEDSB may increase further to values as high as 1.6 to 1.8, although only 
over a small distance very close to the proton range where proton fluence is relatively small compared to that 
incident. Increased scatter in the penumbra regions and in very small fields can also lead to higher RBE values 
due to energy spectrum changes (Stewart et al., 2015; Schmid et al., 2012) . This is particularly relevant for very 
narrowly collimated, highly modulated proton beams, as path length straggling is more dominant in penumbra 
regions leading to lower energy protons that result in higher RBE values. Therefore, a meaningful comparison 
between different particle type and energy beams is only possible when RBE-weighted dose (RWD) is 
considered. To facilitate such comparisons, knowledge of the beam energy fluence per particle per voxel is 
necessary, which itself requires detailed information on the proton and secondary particle energy spectrum 
within the voxel. 
 
Another factor that has complicated the comparison of experimental results derived from beams of different 
energy beams and/or collimator geometries is the lack of a generally accepted dose prescription and reporting 
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formalism for spatially fractionated beams. For synchrotron-based spatially modulated research, the peak and 
valley doses as well as the peak-to-valley dose ratio (PVDR) are generally used dose parameters. For 
comparison with uniform beams, the dose is often specified on the beam entrance side using either Monte Carlo 
simulations and/or physical dosimetry approaches (Siegbahn et al., 2006; Ptaszkiewicz et al., 2008; Brauer-
Krisch et al., 2003; Kaplan et al., 2000; Brauer-Krisch et al., 2015), the latter approach being subject to 
relatively large measurement uncertainties (Crosbie et al., 2008). More recently, prescription attempts have been 
made that use absorbed dose values averaged over a lateral slice of material oriented perpendicular to the beam 
central axis for comparative studies of broad and micro- or mini-beams. For instance, Girst et al. used the mean 
skin dose to design an equipoised experiment to compare spatially fractionated proton pencil beams with a 
uniform proton beam. However, in some beam delivery cases, the Girst et al. prescription approach may not be 
fully appropriate. Our previous simulations of collimator-produced proton minibeams (Lee et al., 2016b) have 
shown that placement of a collimator relative to an irradiated object can have a considerable impact on the peak 
and valley doses as well as on the neutron contribution to the entrance dose (Lee et al., 2016a). This impact was 
also independently verified by Guardiola et al (Guardiola et al., 2017). So even if the mean physical dose 
between modulated and uniformly irradiated scenarios is equivalent, the RWD may not be biologically 
equivalent, especially when proton minibeams are compared to microbeams or broad beams of kV or MV X-
rays.   
 
Explicit considerations of variable RBE and spatial variations in physical dose must be taken into consideration 
when designing experiments to probe for new or refined biological mechanisms of action underlying the 
potential therapeutic advantages of micro- or mini-beam irradiation. In most publications related to micro- and 
minibeam experiments produced by collimation, it is not clear if the exact positioning and orientation of the 
collimator was carefully considered in the dosimetry or if beam spectral changes were considered with beam 
line positioning changes and possibly other components. Of note is one innovative experimental approach to 
determine the dose equivalence between microbeam irradiation and conventional broad beams. Ibahim et al. 
(Ibahim et al., 2014) used clonogenic and cell impedance assays, but highlighted that their dosimetry of the 
synchrotron beam was based on an idealized geometry and it was therefore likely that the valley dose was 
underestimated. Another approach was proposed by Zhang et al. for clinical X-Ray based grid therapy for 
melanoma on a linear accelerator (Zhang et al., 2014a). They used the Linear-Quadratic (LQ) model and 
calculated the equivalent uniform dose (EUD). 
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The aim of this work is to compare and contrast important dosimetric parameters (i.e., mean dose, valley and 
peak dose, EUD), with and without corrections for spatial variations in proton RBE (vRBE) and to establish the 
need to better account for RBE effects in prospective and retrospective analyses of the biological effectiveness 
of spatially fractionated beams. This work is based on Monte Carlo simulations of physical dose, linear energy 
transfer (LET) and RWD using a published Monte Carlo model for DSB induction (Stewart et al., 2011; Stewart 
et al., 2015) as implemented in TOPAS, a Tool for Particle Simulations with Monte Carlo (Polster et al., 2015; 
Perl et al., 2012). As discussed elsewhere (Paganetti, 2014), there is considerable uncertainty in determinations 
of dose-averaged LET and the RBE for various biological endpoints.  However, the use of published biophysical 
models provides a reproducible and plausible framework to explore the potential significance of differences in 
physical dose and RWD as it relates to micro- and mini-beams of photons and protons in comparison to broad 
beams of the same or different types of radiation. To our knowledge, variable RBE considerations have not been 
applied to proton minibeam dosimetry. We also explore the applicability of the EUD concept for these beams 
with and without the inclusion of the RWD and for low and high fraction doses relative to the  ratio, to 
determine a formalism that better enables comparisons of spatially fractionated and uniform beams based on 
DSB induction and the LQ model for cell survival. 
 
2.  Methods 
The University of Washington (UW) research proton beam line was modelled by means of Monte Carlo (MC) 
simulations in TOPAS (Perl et al., 2012), version 3.0.p1. Compared to previous work by our group (Lee et al., 
2016b; Ford et al., 2017), modifications have been made to the proton beamline to integrate it with the isocenter 
of a Small Animal Radiation Research Platform (SARRP) (XStrahl Ltd, Surrey, UK). The changes affected the 
beam characteristics and therefore several components had to be added or moved when depicted in the 
simulations. The UW cyclotron produces a 50.5 MeV monoenergetic proton beam before it enters the research 
beamline. The components modelled in the beamline include 1) a 1.23 mm thick graphite beam degrader 
upstream, 2) a “large” stainless steel beam pipe, 3) a graphite/stainless steel stray beam detector that connects 
the large beam pipe with 4) a smaller stainless-steel beam pipe with inner diameter 35 mm including 5) a 0.15 
mm thick Kapton exit window to contain the vacuum and 6) a protruding small beam pipe downstream of the 
Kapton that is open to air. Between the beam exit window and a water phantom with a 1 mm Lexan entrance 
window is a large Bragg peak ionization chamber (Model T34080, PTW, Freiburg, Germany), henceforth 
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referred to as the monitoring ion chamber. The monitoring ion chamber is necessary to trigger and terminate the 
beam. A multi-slit minibeam collimator can be placed between the monitoring ion chamber and the water 
phantom. A schematic of the beamline from the stray beam detector to the water phantom, but without the 
monitoring chamber, can be found in Lee et al. as Figure 1 (Lee et al., 2016b). A prototype multi-slit collimator 
was made from 25 mm thick SAE 304 steel. It contained thirty-one 300 µm wide slits with a CTC spacing of 1 
mm covering a field size of 3x3cm. The multi-slit collimator was designed to produce a uniform dose at the 
depth of the BP via post collimator scattering in water while retaining the produced high spatial modulation at 
shallow depths in the water. 
 
The exact positioning of the monitoring ion chamber and the water phantom was modelled in TOPAS. 
Simulations were run using 109 proton particle histories. The TOPAS simulations were run on two processors 
(Intel(R) Xeon(R) CPU E5-2697 v3 @ 2.60GHz, with 14 cores each, 256 GB RAM). The voxel dimension 
along the beam axis for simulation computations were 0.05 mm, and 0.8 mm and 0.05 mm along and across the 
direction of the modulation of the beam, respectively. Binary output files were generated and imported into 
MATLAB (MathWorks, Natick, MA, USA) for further analysis.  
 
2.1 Physical dose 
To investigate and verify the beam energy, the first step was to validate the modified beamline model in TOPAS 
without the multi-slit collimator in place. Modelling the beam energy correctly is the basis for accurate 
modelling of the LET and RBE. Percentage depth dose (PDD) measurements were conducted with an Exradin 
Spokas A11 parallel plate ion chamber with a collecting volume of 0.62 cc (Standard Imaging, Middleton, WI, 
USA) and a microDiamond detector (Type 60019, PTW-Freiburg, Germany) with a nominal sensitive volume 
of 0.004 mm³. The A11 ion chamber was manually positioned along the central axis by means of a micrometre 
motion stage in 100 µm steps around the BP and 1 mm in steps in the build-up region. The microDiamond 
detector  was positioned by means of a motion stage (Saini et al., 2017) every 500 µm.  
 
2.2 LET- and RWD for the endpoint of DSB Induction 
The dose-averaged LET, averaged over all protons and secondary particles, was calculated by TOPAS on a per-
voxel basis. Dose-averaged LET is slightly larger than the track-averaged LET (Granville and Sawakuchi, 2015; 
Guan et al., 2015). The RBEDSB within the voxel was simulated using information from the Monte Carlo 
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Damage Simulation (MCDS) (Stewart et al., 2015; Stewart et al., 2011) as implemented in TOPAS (Polster et 
al., 2015). Estimates of RBEDSB, which have been extensively benchmarked against measured data and track 
structure simulations (Stewart et al., 2011; Streitmatter et al., 2017), are based on 60Co -rays as reference 
radiation (Stewart et al., 2015). For electrons and photons, RBEDSB is within a few percent of the RBE for 
reproductive cell survival (Streitmatter et al., 2017). For Z > 1 particles, the repair-misrepair-fixation (RMF) 
model (Carlson et al., 2008) predicts that the RBE for cell survival will be greater than or equal to RBEDSB. 
Thus, the RBEDSB values presented in this work represent the lower bound on the RBE for cell survival for 
comparison to a constant RBE of 1.1. The RWD was computed on a per-voxel basis for both the open and 
spatially modulated beams with the collimator placed at different distances from the water phantom. 
 
2.3 Calculation of Equivalent Uniform Dose 
The equivalent uniform dose is defined as “the uniform dose that, if delivered over the same number of fractions 
as the non-uniform dose distribution of interest, yields the same radiobiological effect” (AAPM Task Group 
166, 2012). The EUD (Niemierko, 1997) was applied to evaluate and compare uniform with non-uniform 
irradiation geometries. For the endpoint of cell survival, the EUD is given by 
 
  = ∝⁄ −1 + 1 −
̅
( ⁄ ) , where =  ∑ − − . (1) 
 
 and  are parameters in the LQ cell survival model, ̅ is the surviving fraction (SF),  is the volume of a 
single voxel, = ∑  is the total volume of the region of interest (ROI), and   the number of voxels in 
the ROI. In this work, the concept of EUD is explored with both the physical dose, D, and the RBE-weighted 
dose, RWD (instead of D).  is the 60Co γ-ray absorbed dose delivered to the ith voxel that creates the same 
number of DSB per cell as proton absorbed dose × . For the special case when = = / , the 
surviving fraction averaged over all n voxels computed using RWD is 
 
  ̅ =  ∑ − − = ∑ − 1 + ( ⁄ ) . (2) 
 
For the special (“low dose”) scenario when ≪ ( ⁄ ), . (2) reduces to 
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  ̅ =  ∑ (− ). (3) 
 
For the sake of this comparison, we do not distinguish between tumour cells and normal tissues per se but 
investigate the concept more generally for a representative range of  ratios (1 and 10 Gy). To bracket the 
range of radiosensitive to radioresistant tissues, we assume surviving fractions between 0.1 and 0.95, 
respectively, after uniform irradiation by a 2 Gy proton dose at the BP. The EUD formalism was calculated in 
MATLAB and applied to the imported physical and dose-averaged RBE from TOPAS. Both the mean doses and 




Figure 1 shows the energy spectrum at various stages along the beam delivery system of the initially 
monoenergetic 50.5 MeV proton beam emerging from the cyclotron. The fluence after the degrader is reduced 
by >90%. The aim of the degrader is to produce a uniform beam at the end of the beam pipe. Both the degrader 
as well as the monitoring ion chamber reduce the peak energy by about 2-3 MeV resulting in a dominant peak 
energy of 45 MeV after the monitoring ion chamber with a narrow energy spread of ±0.5 MeV. There is a tail of 
proton energies between 25 and 42 MeV with a maximum of 0.9% of the counts at the peak energy (see proton 
energy histogram in Figure 2a). The tail primarily stems from particles scattered off the beam pipe wall. In 
Figures 2b-d, the effect of the minibeam collimator on the proton energy spectrum is shown (secondary axis) 
when placed flush and at 2 and 5 cm distant from the water phantom, respectively. Also shown in Figure 2 
(primary axis) is the corresponding relative neutron fluence. The relative magnitude of the maximum neutron 
fluence is less than 0.8% with the collimator flush and 0.3% and 0.2% when placed at 2 and 5 cm distant from 
the surface, respectively.  
 
For the measured PDDs for the open beam, the depth of 17.0 mm for the BP agrees well with the simulations 
(Figure 3). The plots were normalized to 1 mm depth. The depth of the BP corresponds to the beam’s most 
probable incident energy and the sharpness of the BP corresponds to the degree of energy distribution spread in 
the beam about the BP depth. The agreement between the modelled and measured depth-dose curves validates 
that the Monte Carlo model adequately represents the UW proton beam line. The Bragg-peak-to-entrance-ratios 
(BPER) were 4.8:1, 4.3:1 and 3.9:1 for the simulated beam, the ion chamber measurement and the 
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microdiamond measurement, respectively. The difference in the peak dose at the BP reflects the different 
resolution of the simulated and measured data and the resulting volume averaging effect in the detectors used.  
 
A comprehensive analysis of the open beam PDD (dose) compared to the RWD based on both a constant RBE 
of 1.1 (cRWD) and the computed variable RBEDSB (vRWD) are shown in Figure 4. The graphs illustrate the 
RBE effects of the proton beam in the absence of a collimator. The LET, a constant RBE of 1.1 (cRBE) and the 
RBEDSB (vRBE) are plotted in Figure 4b. The relative differences in RBE and the absolute differences in RWD 
are shown in Figure 4c and 4d, respectively. LET values for the beam at depth were 2.7 keV/µm at 10 mm, and 
4.8 keV/µm at 15 mm. LET increased near-linearly to 15.1 keV/µm at the BP and reached a maximum value of 
30.1 keV/µm at the distal end of the BP. A similar behaviour with depth was exhibited for RBEDSB with 
predicted values of 1.05, 1.1, 1.4 and 1.9, corresponding to the above depths, respectively.  
 
For comparison, we also computed RBEDSB for a range of energies on our beamline (without multi-slit 
collimator) to examine the energy dependence and magnitude of the RBEDSB over the range of available 
energies at other proton minibeam facilities. The results are given in Table 1. The expected penetration in water 
of a nominally 20 MeV beam is approximately 4 mm. However, no meaningful data could be obtained with our 
beam components, given the attenuation along the UW beamline at such a low energy, and therefore no values 
are included. LET and RBEDSB values comparing the non-collimated (open) beam with the collimator at 
different distances from the phantom are shown in Table 2. 
 
The RBE effects on the dose profiles are shown in Figure 5. Figures 5a-b show the dose and the RWD at the 
phantom surface and at the depth of the BP with the collimator placed flush with the water phantom, 
respectively. In Figures 5e-f, the corresponding information is displayed for the collimator placed at 2 cm from 
the water phantom. Figures 5c-d and 5g-h show the relative difference between the dose and RWD, respectively.  
 
The PDDs through the central peak and valley for the collimated beam are shown in Figure 6. A comparison of 
the mean dose and EUD range for different  ratios and surviving fractions is also shown for two scenarios. 
Figures 6a and 6b correspond to the collimator flush with the water phantom and Figures 6c and 6d show the 
collimator placed at 2 cm distance. Figures 6a and 6c refer to the physical absorbed dose and Figures 6b and 6d 
to the RWD along the central axis. The graphs are normalised to 2 Gy at central axis (peak). Figures 6e and 6f 
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are similar to Figures 6c and 6d, respectively, except that the dose was normalized to 20 Gy, to highlight its 
impact on the EUD. 
 
4. Discussion 
Determining the biologically equivalent dose deposited by a polyenergetic proton beam requires exact 
knowledge of the beam’s spectrum as a function of spatial location in the absorbing medium. To gain this 
knowledge, we developed a Monte Carlo simulation model of the University of Washington PPRP beamline 
including all of its pertinent components. The beam energy of this model was verified by means of PDD 
measurements (Figure 3) and a comprehensive analysis was carried out with respect to the influence of the most 
relevant components of the beam spectrum (Figure 1 and 2a). Although the beam is degraded by about 5 MeV 
along the beam path, to a peak energy of 45 MeV, the initially monoenergetic proton beam remains mostly 
pristine with only a small energy spread of ±0.5 MeV. This is important as the sharpness of the BP is greatest 
for a monoenergetic beam and deteriorates when the proton energy spectrum broadens. To generate spatially 
modulated beams, the beam spot can either be scanned (Klodowska et al., 2015) or generated by a multi-slit 
collimator (Lee et al., 2016b). The effects of a multi-slit collimator for proton minibeams at different distances 
from a phantom were modelled and the results are shown in Figure 2. The collimator does not further degrade 
the proton energies within the beam; rather, it results in a slight narrowing of the 45 MeV peak and reduces the 
tail of scattered energies between 35 and 42 MeV regardless of its position relative to the phantom. However, 
the neutron contribution increased when the collimator was introduced, especially when the collimator was 
placed flush with the phantom surface, leading to an increase by approximately a factor of 8 (Figure 2b). 
Overall, the neutron contribution is very small, less than 1% of the proton counts, but due to the higher RBE of 
neutrons, and subsequently higher RWD, the relative biologically relevant dose contribution is higher. The 
neutron contribution at the phantom surface reduces sharply as a function of distance of the collimator from the 
phantom surface and is almost equivalent to that of a non-collimated beam when placed 5 cm distant from the 
surface. These observations are in line with our previous findings (Lee et al., 2016a) and those independently 
made by Guardiola et al. (Guardiola et al., 2017). Thus, to decrease the number of neutrons on the surface, the 
collimator should be placed away from the entrance. Unfortunately, this also will decrease the collimator’s 
effective degree of spatial modulation, i.e. the PVDR. For the current collimator simulations, the PVDR at the 
entrance was 37 when the collimator was placed flush (Figure 6a) and reduced by a factor of 10 to 3.7 at 2 cm 
distant from the surface (Figure 6c). This further highlights the strong dependency of the dosimetry of these 
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spatially modulated proton beams on the position of the collimator relative to the irradiated object, as previously 
described (Lee et al., 2016b; Guardiola et al., 2017). 
 
RBE considerations 
Although DSB are widely considered one of the more biologically challenging forms of DNA damage to repair, 
the majority (> 95-97%) of the initial DSB formed by ionizing radiation are correctly rejoined. The Repair-
Misrepair-Fixation (RMF) model (Mairani et al., 2016; Carlson et al., 2008; Frese et al., 2012; Streitmatter et 
al., 2017) explicitly links the formation and subsequent biological processing of initial DSB to the formation of 
lethal and non-lethal chromosome aberrations. In the RMF model, the RBE for cell survival in the limit as the 
dose becomes large compared to () is exactly equal to RBEDSB. For doses comparable to or smaller than 
(), the interactions of pairs of DSB formed by the same track (intra-track binary misrepair) are more likely to 
form lethal damage than pairs of DSB formed by different tracks (inter-track binary misrepair). These proximity 
effects (Hlatky et al., 2002) imply that the low dose RBE for cell survival (RBELD) is greater than the high dose 
RBE (RBEHD) for cell survival. For protons, Carabe-Fernandez et al. (Carabe-Fernandez et al., 2007; Carabe-
Fernandez et al., 2010) also found that the RBE for cell survival decreases with increasing dose, i.e., RBEmax = 
RBELD and RBEmin = RBEHD. For proton mini-beams, it is reasonable to expect the RBE for cell survival to 
approach RBEmin = RBEHD = RBEDSB in regions of tissue in which the peak or valley dose is comparable to or 
exceeds ().  Additional work is needed to examine RBE effects in spatially modulated particle beams in the 
limit of valley or peak doses that are small compared to (). 
 
The relative contribution of the different particles and energies in the beam have an effect on the spatial 
distribution of RWD. The implementation of the MCDS model of RBEDSB into TOPAS allows this dependency 
to be modelled on a per-voxel basis. Before investigating the spatially modulated beam, the LET and RBEDSB 
distribution along the central axis were examined for an open beam to serve as a reference. For comparison with 
other facilities that have a proton minibeam, simulations were run for energies published in the range 30 to 109 
MeV. To reiterate, the values provided in Table 1 reflect the nominal beam energies of the mono-energetic 
proton beam before entering the beam pipe on the UW beam line. The beam energy incident at the phantom 
surface is therefore lower and might be different if injected into a beamline at another facility. The purpose of 
the comparison was to get a sense of the approximate differences in biologically equivalent dose between 
different facilities where investigators are exploring spatially fractionated proton beams. This is important when 
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comparing results generated by different beamlines. The values show that, as expected, both LET and RBEDSB 
decrease with increasing beam energy. However, for the 50.5 MeV beam and higher energies, the RBEDSB at 1 
mm depth is nearly identical (1.03 ± 0.01); the same is true at the BP, where the RBE is 1.33 ± 0.08. The 
RBEDSB towards the distal end of the BP shows higher variation, but due to the lower physical dose delivered, 
this typically has less of an impact. For lower energies, the RBEDSB increases more drastically. Overall, the 
RBEDSB values between the surface and depth of the BP are, while continuously changing, comparable for 
nominal energies between 50-109 MeV. For lower energy beams not included here, higher LET and RBEDSB 
values are expected.  
 
For the UW 50.5 MeV beam, both LET and RBEDSB follow a similar trend with noisier values towards the distal 
end of the BP (Figure 4). The RWD is close in value to the relative physical dose between the surface and the 
proximal side of the BP. The steep near-linear increase in RBEDSB starts at about 1 mm before and ends 1 mm 
after the BP. For clinical beams at higher energies, a constant RBE of 1.1, referred to as cRBE, is typically used. 
It is shown in Figure 4 that along the CAX a constant RBE of 1.1 overestimates RBEDSB by approximately 5% 
down to a depth of 12 mm, then the two are about equal for a few mm before RBEDSB increases sharply. The 
near-linear trend in the LET and RBEDSB towards the end of the beam is not reflected in the RWD difference 
between the vRWD and the cRWD (Figure 4d). Effectively the largest RWD difference is past the BP at a depth 
of 17.15 mm and tapers off to either side. 
 
Table 2 shows that placing a collimator in the beam path does not substantially affect the LET and RBEDSB 
values at the BP. The effects of the RWD for a modulated beam generated with a steel collimator are shown in 
Figures 5 and 6. Note that Figure 5 is normalized to the CAX at 1 mm depth and Figure 6 to the CAX at the 
depth of the BP. At shallow depths, the valleys and peaks are about 5% lower than the constant RBE value of 
1.1 that is commonly clinically assumed (Figure 5c and 5g). While this does not affect the PVDR considerably, 
it does lead to lower valley doses, which have been reported to correspond to the normal tissue tolerance of 
uniformly irradiated beams (Siegbahn et al., 2006). At a depth around the BP, the higher RWD result in higher 
peak doses by a factor of 43% at the BP (Figures 5d and h). When the RWD is normalized to the BP, as was 
done for Figure 6, the relative entrance valley doses are therefore reduced. Also of note are the increased 
RBEDSB values in the penumbra regions resulting in an increased RWD. This can be seen in Figures 5c-d and 
5g-h. While the physical dose between the collimator placed flush with the phantom (Figure 5a-b) and at 2 cm 
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distant (Figure 5e-f) are quite different, especially in the valley regions, the relative differences are identical 
(compare Figures 5c-d with Figures 5g-h) indicating that no noticeable RBEDSB changes take place in the 
penumbra for the two different collimator positions. This is because the collimator produced minibeam energy 




Zeman and Curtis (Zeman et al., 1961; Zeman et al., 1959) observed the radiosensitivity of small tissue volumes 
was dramatically decreased when irradiated by microbeams of X-rays compared to uniform beam irradiation. A 
satisfactory explanation of this phenomenon remains elusive. However, separating the contribution of known 
radiation response observation influence factors such as RBE and EUD between the two very different radiation 
delivery approaches is an important step toward other identifying possible explanations for the overall 
phenomenon. Although the EUD concept lends itself well to characterize non-uniform 3D dose distributions, it 
is not without limitations and may not fully account for all radiation biological response factors. The LQ model 
is inadequate to capture all dose-response characteristic factors for tumour or tissue, such as e.g. re-oxygenation, 
repopulation, re-distribution of cells in cell cycle, vascular damage and immune response. The LQ model only 
corrects for repair and may or may not be sufficiently accurate as the dose per fraction becomes large compared 
to (Brown et al., 2014; Kirkpatrick et al., 2008; Brenner, 2008). It has also recently been reported that the 
LQ model may not be adequate to predict the response for spatially fractionated fields as it does not sufficiently 
account for bystander effects (Peng et al., 2017). Consequently, the above plus other unknown biological 
processes that possibly contribute to the overall response of the cells within or near a tissue region of interest 
may not be captured by EUD when radiation response is elicited by highly spatially fractionated beams. With 
this in mind, when comparing uniform with spatially fractionated dose distributions it is therefore imperative to 
compute the EUD to be able to separate known from unknown factors. For synchrotron based microbeam 
radiotherapy, decreased radiosensitivity effects have commonly been referred to as the “normal tissue sparing 
effect” (Dilmanian et al., 2007).  
 
To investigate the influence of the EUD on different sensitivity cells and as a function of dose (c.f. Eq. 1 & 2), 
the EUD was calculated for 2 Gy and 20 Gy at the BP for a range of surviving fractions (0.1 to 0.95) and 
ratios (1 and 10 Gy) for the UW proton mini beam. This EUD dependency is shown together with the mean 
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dose in the plot of the PDDs in the peak and valley regions in Figure 6. Figure 6c-d show that the EUD is close 
to the mean physical dose and the mean RWD but not identical when the collimator is 2 cm distant. The larger 
difference is seen for the collimator placed flush (Figure 6a-b). While the overall difference between the mean 
dose and EUD is indistinguishable in the BP region, the difference is most obvious on the beam entrance side 
down to about 10 mm depth. The higher neutron contribution with the collimator placed flush (Figure 2a) is the 
main contributing factor for this observation. Therefore, the BP dose is relatively uniform and the physical dose, 
the EUD and mean dose are very similar per their definition. For the higher  ratios, the EUD tends to be 
lower than the mean dose, whereas for the lower ratios the EUD tends to be higher. In terms of the peak and 
valley doses, the difference in the shape of the PDDs between the different collimator positions is substantial. In 
Fig. 6c-d, the relative peak dose along the collimator slit is much lower and remains nearly constant with depth 
down to the proximal end of the BP, whereas the relative valley dose increases somewhat. Despite the 
differences in the PVDR between the collimator placed flush and 2 cm distant, the mean dose and the mean 
RWD are nearly identical as pointed out above. Increasing the dose to 20 Gy thus does not affect the relative 
mean dose. However, since the EUD is dependent on dose, large deviations between the EUD and the mean 
dose can occur. For larger doses, the EUD tends towards the valley dose, especially for the radiosensitive cells 
(SF= 0.1) regardless of ratio. It can be clearly seen that for large doses the mean dose and mean RWD 
overestimate the EUD.  Therefore, the mean dose and mean RWD are not adequate metrics to compare uniform 
and non-uniform proton beams for the endpoint of reproductive cell survival.  
 
This work primarily investigates proton minibeams but is also relevant more generally for X-Ray based spatially 
modulated microbeams for which cell and small animal data are available. For example, early small animal 
experiments that reported extraordinary normal tissue sparing and a greater therapeutic index of modulated 
synchrotron microbeams used median X-ray energies in the range 50-70 keV (Laissue et al., 1998; Dilmanian et 
al., 2002) with peak skin entrance doses as high as 500 Gy. RBE and EUD considerations would most likely 
affect the reported results, such as e.g. a reported gain in therapeutic index of a factor of ~5 (Dilmanian et al., 
2002) for microbeam therapy over uniform irradiation. This is not to say that bystander effects have no 
additional significance for modulated beams, which in fact has been demonstrated consistently. On the contrary, 
accounting for the biological dose equivalence of modulated and uniformly irradiated beams enables better 
experimental design and reporting of the aforementioned effects. The experimental verification of the models 
and considerations presented in this work should be the next step and remains an area of further work.  
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5. Conclusion  
Proton minibeams in the energy range 20-109 MeV exhibit relatively large RBE variations, especially around 
the BP and the penumbra regions. These variations can be modelled with Monte Carlo simulations and should 
be reported for dosimetric and experimental studies. For comparison of spatially fractionated and uniform dose 
distributions the EUD can considerably deviate from the mean dose, especially for high radiation doses and 
radiosensitive tumours. Both RBE and EUD corrections are strongly recommended when designing and 
reporting about comparative studies between uniform and highly spatially fractionated dose distributions. This 
will facilitate fair comparisons between different type beams and interinstitutional experimental setups as well 
as better quantification of the effects that may not be adequately described with the LQ model. 
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Figures 
  
Fig. 1:   Analysis of the effects of beam components on the proton energy spectrum for the open 3.5 cm 
diameter 50.5 MeV proton beam from the UW cyclotron. Each energy bin is 0.25 MeV. 
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Fig. 2:  Proton (black) and neutron (green) energy spectra at entrance of water phantom with a) no 
collimator, b) collimator placed flush at water phantom, c) collimator placed at 2 cm distance and d) 
collimator placed at 5 cm distance from the water phantom. Left axis shows relative neutron counts 
and right axis relative proton counts. Note that the proton counts for the open beam in a), 
corresponding to p+ after monitoring ion chamber in Fig. 1, are truncated to be on the same scale as 
the collimated beam (Figs. 2b-d).  
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Fig. 3: Comparison of the measured vs modelled PDDs for the open field. 
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Fig. 4: Percentage depth dose comparison of physical vs biological dose. a) Physical dose (dose) vs RWD 
based on a constant RBE of 1.1 (cRWD) vs RWD based on variable RBEDSB (vRWD), b) cRBE and 
RBEDSB (vRBE) as a function of depth (primary axis on left) plus LET as a function of depth 
(secondary axis on right), c) percentage difference between RBEDSB and cRBE with depth, d) 
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Fig. 5: Dose profiles of physical dose vs RWD normalized to dose at central axis at 1 mm depth. a) at surface 
for collimator flush, b) at BP for collimator flush, c) relative difference at surface for collimator 
flush, d) relative difference at BP for collimator flush, e) at surface for collimator at 2 cm distant, f) at 
Bragg peak for collimator at 2 cm distant, c) relative difference at surface for collimator at 2 cm distant, d) 
relative difference at BP for collimator at 2 cm distant. 
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Fig. 6:  Comparison of mean dose versus EUD for absorbed dose along CAX (a, c, e) and RWD (b, d, f) for 
a range of /  and =0.1 to 0.95 for proton minibeams. The dashed EUD lines correspond to =0.1 
(radiosensitive) and the solid lines to =0.95 (radioresistant). a) 2 Gy dose with collimator flush b) 2 
Gy dose with collimator at 2 cm distance, c) RWD corresponding to a), d) RWD corresponding to 
b), e) 20 Gy dose with collimator at 2 cm distance, f) RWD corresponding to e). PVDR: Peak-to-
valley-dose-ratio, BPER: Bragg-peak-to-entrance-dose-ratio. 
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1 mm 1.12 4.64 1.04 2.24 1.04 2.00 1.04 1.19 1.02 1.09
BP 1.57 20.00 1.43 15.13 1.34 12.06 1.28 10.02 1.26 9.65
distal  end 2.02 38.07 1.85 30.09 1.73 28.40 1.49 18.05 1.38 13.58
84.0
location
depth BP (mm) 3.2 17.0 27.0 71.3
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Table 2: LET and RBEDSB values at the BP with and without collimator for UW beamline with 50.5 MeV 








LET @BP 15.1 16.3 15.4 14.6
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